Drug Type Cell therapy |
Synonyms- |
Target |
Mechanism NCF1 modulators(neutrophil cytosolic factor 1 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
RegulationOrphan Drug (US) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Granulomatous Disease, Chronic | Discovery | US | 01 Mar 2023 |